A Biotech Play “On The Right Side Of Volatility”

  • by

When it comes to stock selection, avoiding losers is just as important – and maybe even more important – than picking winners. This is why the author of today’s article urges readers to avoid the most volatile stocks in the market, which he calls “high-beta bombs”. After having identified 10 high-beta biotech bombs to avoid, he now highlights a biotech play that’s on the right side of volatility: a blue-chip biopharmaceutical company with an emphasis on diabetes and obesity treatments. For more, CLICK HERE.